DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Twist Bioscience
publicFounded 2013

Twist Bioscience

HQ: South San Francisco, CA, USACEO: Emily LeproustHeadcount: 800+twistbioscience.com
Funding Summary
Total Funding
$900M+
Latest Valuation
~$2B (public market cap)
About

Leading synthetic DNA manufacturer using a proprietary silicon-based platform for high-throughput, low-cost gene synthesis. Critical infrastructure for the entire synbio ecosystem.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →